Comparing Inhalation and Total Intravenous Anesthesia Methods (TIVA-IHA)
Comparison of Patient Outcomes Between Anesthesia Administered Via Target-controlled Infusion Method and Inhalation Anesthesia Method in Pediatric Patients Undergoing Inguinal Hernia Repair
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Özlem OZ GERGIN, MD
- Phone Number: 09005332466396
- Email: oozgergin@erciyes.edu.tr
Study Locations
-
-
-
Kayseri, Turkey (Türkiye)
- Özlem OZ GERGİN
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Children aged 3-12 years
- Patients weighing over 10 kilograms
- Patients who will undergo inguinal hernia surgery
- ASA (American Society of Anesthesiologists) classification I and II pediatric patients.
Exclusion Criteria:
- Absence of systemic illness.
- ASA (American Society of Anesthesiologists) classification III pediatric patients.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
TOTAL INTRAVENOUS ANESTHESIA GROUP
After premedication, anesthesia induction will be performed as per routine.
Upon reaching the target Bispectral Index (BIS) level (40-60) and ensuring muscle relaxation, the airway will be secured with an appropriately sized endotracheal tube or laryngeal mask airway (LMA).
The target concentration of Propofol in the effect site will be set at 3 mcg/ml using a Target-Controlled Infusion (TCI) device.
Controlled ventilation will be conducted with 50% oxygen/air mixture, adjusting mechanical ventilation parameters to maintain End-Tidal Carbon Dioxide (EtCO2) levels between 35-45 mmHg.
|
TCI (Target-Controlled Infusion) is a method used to maintain the dose and rate of anesthesia drugs within a target concentration range set by the anesthetist.
This system delivers drugs intravenously to the patient using a computer-controlled pump.
The anesthetist adjusts the drug concentration to achieve the desired depth of anesthesia.
This method provides more precise control over anesthesia and facilitates maintaining the depth of anesthesia within the desired range.
Other Names:
|
|
The Patient Group Receiving Inhalation Anesthesia
Patients will be induced with the same anesthesia as Group I, and BIS values will be adjusted to be between 40-60 at the routinely used inhalation gas level of sevoflurane.
Patients will be given controlled ventilation with 50% Oxygen/air, and mechanical ventilation materials will be adjusted so that the end tidal carbon dioxide level (EtCO2) will be 35-45 mmHg.
|
In the inhalation anesthesia group, maintenance sevoflurane anesthesia will be applied after routine induction.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Modified Aldrete Scoring System
Time Frame: after surgery 1 hours
|
The effects on recovery were monitored within the first hour of the postoperative period using the Modified Aldrete Scoring System (MASS).
Totally 0-10 points can be given by MASS.
Higher scores predicts better recovery.
|
after surgery 1 hours
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
blood pressure (mmHg)
Time Frame: after surgery 1 hours
|
The blood pressure of the patients will be measured and recorded in mmHg at five-minute intervals from the beginning until the first postoperative hour.
|
after surgery 1 hours
|
|
heart rate (Beats/minute)
Time Frame: after surgery 1 hours
|
The heart rate of the patients will be measured and recorded in mmHg at five-minute intervals from the beginning until the first postoperative hour.
|
after surgery 1 hours
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Özlem OZ GERGİN, MD, TC Erciyes University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathological Conditions, Anatomical
- Hernia
- Hernia, Abdominal
- Pathological Conditions, Signs and Symptoms
- Hernia, Inguinal
- Physiological Effects of Drugs
- Anesthetics
- Central Nervous System Depressants
- Anesthetics, General
- Organic Chemicals
- Ethers
- Pharmacologic Actions
- Chemical Actions and Uses
- Therapeutic Uses
- Hydrocarbons
- Hydrocarbons, Halogenated
- Central Nervous System Agents
- Hydrocarbons, Fluorinated
- Methyl Ethers
- Sevoflurane
- Anesthetics, Inhalation
Other Study ID Numbers
Other Study ID Numbers
- 2022/200
- TDK-2022-11979 (Other Grant/Funding Number: TDK-2022-11979)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.